217 related articles for article (PubMed ID: 6173340)
21. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
22. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
Lehotay DC; Levey BA; Rogerson BJ; Levey GS
Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
[No Abstract] [Full Text] [Related]
23. Cytotoxic and antitumor antibiotics produced by microorganisms.
Oki T
Biotechnol Bioeng; 1980; 22 Suppl 1():83-97. PubMed ID: 6159010
[No Abstract] [Full Text] [Related]
24. Antitumor activity of new N-substituted daunorubicin derivatives.
Mazerska Z; Woynarowska B; Stefanska B; Borowski E; Martelli S
Drugs Exp Clin Res; 1987; 13(6):345-51. PubMed ID: 3308387
[TBL] [Abstract][Full Text] [Related]
25. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
Meriwether WD; Bachur NR
Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
[No Abstract] [Full Text] [Related]
27. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
28. [Antitumor activity of macromomycin].
Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
[TBL] [Abstract][Full Text] [Related]
29. [Bleomycin, a new antibiotic possessing antitumor properties].
Vermel' EM
Vopr Onkol; 1972; 18(9):85-93. PubMed ID: 4126161
[No Abstract] [Full Text] [Related]
30. Cellular accumulation and disposition of aclacinomycin A.
Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
[TBL] [Abstract][Full Text] [Related]
31. Anthracycline antibiotic 2-hydroxyaclacinomycins. II. Production of 2-hydroxyaclacinomycins A and B by a new recombinant strain and their antitumor activities.
Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
Jpn J Antibiot; 1991 Mar; 44(3):277-86. PubMed ID: 1880910
[TBL] [Abstract][Full Text] [Related]
32. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
[TBL] [Abstract][Full Text] [Related]
33. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
Skovsgaard T
Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
[No Abstract] [Full Text] [Related]
35. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
Marzin D; Jasmin C; Maral R; Mathe G
Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
[TBL] [Abstract][Full Text] [Related]
36. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
[No Abstract] [Full Text] [Related]
37. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
38. Interaction of anthracyclines with covalently closed circular DNA.
Mong S; DuVernay VH; Strong JE; Crooke ST
Mol Pharmacol; 1980 Jan; 17(1):100-4. PubMed ID: 6155600
[No Abstract] [Full Text] [Related]
39. Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.
Penco S; Casazza AM; Franchi G; Barbieri B; Bellini O; Podestà A; Savi G; Pratesi G; Geroni C; Di Marco A; Arcamone F
Cancer Treat Rep; 1983; 67(7-8):665-73. PubMed ID: 6575865
[TBL] [Abstract][Full Text] [Related]
40. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
Soga K; Furusho H; Mori S; Oki T
J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
